跳至主要内容
临床试验/CTRI/2024/11/077008
CTRI/2024/11/077008尚未招募3 期

A Comparative Study on the Effectiveness of ARSENICUM SULPHURATUM FLAVUM and INDIVIDUALIZED HOMOEOPATHIC MEDICINES in the Treatment of VITILIGO

Dr Swiyana B H1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2024年11月25日最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
50
试验地点
1
主要终点
Clinical study:

研究概览

简要总结

Vitiligo is a cosmetically disfiguring and a stigmatizing condition, leading to psychological problems and having a great impact on the quality of life. Since there is no causative treatment available, current conventional treatments are directed toward stopping the progression of the depigmentation and achieving re-pigmentation and the treatment is very costly; whereas homeopathic medicines have shown to be clinically very effective in treating vitiligo and is also affordable for the patients. But the research studies conducted on homeopathic treatment of vitiligo are only a few. The primary objective of the study is to assess the changes in VASI and VitiQoL scoring indices of patients with Vitiligo before and after administration of individualized homoeopathic medicines as compared to  Arsenicum Sulphuratum Flavum, which had been specifically used for vitiligo and leucoderma by many homoeopathic practitioners.

NULL HYPOTHESIS : There is no significant difference in VASI and VitiQoL scoring indices of patients with Vitiligo before and after treatment with Arsenicum Sulphuratum Flavum as compared to Individualized Homeopathic Medicines.

ALTERNATIVE HYPOTHESIS : There is a significant difference in VASI and VitiQoL scoring indices of patients with Vitiligo before and after treatment with Arsenicum Sulphuratum Flavum as compared to Individualized Homeopathic Medicines.

研究设计

研究类型
Interventional
分配方式
Na
盲法
None

入排标准

年龄范围
10.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • Patients presenting with clinical signs and symptoms of Vitiligo.
  • Those who are willing to give written, informed consent; parental consent for those under the age of 18.

排除标准

  • Leucoderma
  • Cases with serious systemic illness
  • Patients with malignancies
  • Pregnant and lactating females.

结局指标

主要结局

Clinical study:

时间窗: After 1 Year (after completion of the study)

Assessment of the changes in VASI and VitiQoL scoring indices of patients with Vitiligo before and after administration of

时间窗: After 1 Year (after completion of the study)

Arsenicum Sulphuratum Flavum as compared to Individualized Homoeopathic Medicines.

时间窗: After 1 Year (after completion of the study)

次要结局

  • Assessment of the relation of Vitiligo with Hypothyroidism, Diabetes Mellitus & Rheumatoid arthritis.(Required baseline investigations will be done at 0,26 & 52 weeks.)

研究者

发起方
Dr Swiyana B H
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Dr Swiyana B H

Government Homoeopathic Medical College, Thiruvananthapuram

研究点 (1)

Loading locations...

相似试验